3-4

MJ Biopharm Pvt. Ltd. is the flagship company of the MJ Group, formed to facilitate Quality Healthcare through its highly specialized range of pharmaceutical products / formulations in the domestic and export market. The company excels in animal and human rDNA Insulin and other dosage forms such as tablets, capsules, cephalosporin injectables, other injectable ampoules and vials in different specialty segments such as Diabetology, Cardiology, NSAID, Anti-inflammatory, Anti-biotics etc.

Venus Remedies India is a research and development driven, pharmaceutical manufacturing company. Among the top 50 Indian Pharma companies of India, the company has out paced most Indian pharmaceutical companies in its growth and value creation over the past few years.

Post: G.Manager - Business Development

Ashish Life Science Pvt. Ltd. is a part of Ashish Group of Industries established since 1975. The company over a period of time has established its name in the National and International market by providing a very high level of customer satisfaction by our dedicated and committed team of people.

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits

Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia.

Shreya Life Sciences is the Indian arm of Moscow based Shreya Group which currently operates in India, Russia, CIS countries and Africa. Shreya is one of the market leaders in Antiplatelet segment, Gl care, Nutritionals, Antimalarials & Antibiotics, Insulin, Cardiology & Diabetology markets.

PAREXEL has developed significant expertise to assist clients in the worldwide pharmaceutical, biotechnology and medical device industries with the development and launch of their products in order to bring safe and effective treatments to the global marketplace for the patients who need them. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 54 countries around the world, and has over 9,500 employees.